0000950170-24-052857.txt : 20240503 0000950170-24-052857.hdr.sgml : 20240503 20240503160106 ACCESSION NUMBER: 0000950170-24-052857 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240502 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Babler Martin CENTRAL INDEX KEY: 0001435618 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 24912847 MAIL ADDRESS: STREET 1: C/O INFINITY PHARMACEUTICALS, INC. STREET 2: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0508 4 2024-05-02 0001785173 89bio, Inc. ETNB 0001435618 Babler Martin C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 true false false false false Stock Option (Right to Buy) 8.86 2024-05-02 4 A false 67700 0.00 A 2034-05-02 Common Stock 67700 67700 D This option represents a right to purchase a total of 67,700 shares of the Issuer's Common Stock, which vests in equal installments on April 13, 2025, April 13, 2026 and April 13, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. /s/ Ryan A. Murr, as attorney-in-fact for Martin Babler 2024-05-03